1. Home
  2. SLNO vs FRSH Comparison

SLNO vs FRSH Comparison

Compare SLNO & FRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • FRSH
  • Stock Information
  • Founded
  • SLNO 1999
  • FRSH 2010
  • Country
  • SLNO United States
  • FRSH United States
  • Employees
  • SLNO N/A
  • FRSH N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • FRSH EDP Services
  • Sector
  • SLNO Health Care
  • FRSH Technology
  • Exchange
  • SLNO Nasdaq
  • FRSH Nasdaq
  • Market Cap
  • SLNO 3.7B
  • FRSH 3.7B
  • IPO Year
  • SLNO 2014
  • FRSH 2021
  • Fundamental
  • Price
  • SLNO $49.68
  • FRSH $12.22
  • Analyst Decision
  • SLNO Strong Buy
  • FRSH Buy
  • Analyst Count
  • SLNO 9
  • FRSH 16
  • Target Price
  • SLNO $114.89
  • FRSH $19.44
  • AVG Volume (30 Days)
  • SLNO 2.3M
  • FRSH 4.1M
  • Earning Date
  • SLNO 11-04-2025
  • FRSH 11-05-2025
  • Dividend Yield
  • SLNO N/A
  • FRSH N/A
  • EPS Growth
  • SLNO N/A
  • FRSH N/A
  • EPS
  • SLNO N/A
  • FRSH N/A
  • Revenue
  • SLNO $98,675,000.00
  • FRSH $810,640,000.00
  • Revenue This Year
  • SLNO N/A
  • FRSH $17.01
  • Revenue Next Year
  • SLNO $181.30
  • FRSH $13.02
  • P/E Ratio
  • SLNO N/A
  • FRSH N/A
  • Revenue Growth
  • SLNO N/A
  • FRSH 18.18
  • 52 Week Low
  • SLNO $41.50
  • FRSH $10.51
  • 52 Week High
  • SLNO $90.32
  • FRSH $19.77
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 38.19
  • FRSH 63.22
  • Support Level
  • SLNO $46.82
  • FRSH $10.52
  • Resistance Level
  • SLNO $50.78
  • FRSH $12.26
  • Average True Range (ATR)
  • SLNO 3.70
  • FRSH 0.39
  • MACD
  • SLNO -1.37
  • FRSH 0.16
  • Stochastic Oscillator
  • SLNO 25.56
  • FRSH 95.11

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About FRSH Freshworks Inc.

Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CS and ITSM categories and has also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and serve their customers and employees. The group derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and Other regions.

Share on Social Networks: